Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
10-15%
EC/CAS
203-615-4/108-78-1
Name of the chemical
Melamine
Concentration
5-10%
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.01%
General Information
Version
05/09/2025
Revision date
2024-12-13
Product name
PROTECTA STEEL PAINT FR-1
1.2.1 Relevant identified uses
or Paint
1.2.2. Uses advised against
Restricted to professional users
Manufacturer Name
Polyseam Ltd
Emergency telephone
0344 892 0111, 0845 4647
Icons in SDS
Company Information
company name
Polyseam Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
post.uk@polyseam.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361f
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Carc. 2; H351, Suspected of causing cancer. Repr. 2; H361f, Suspected of damaging fertility.
Signal word
Warning
Hazard statements
Suspected of causing cancer. (H351) Suspected of damaging fertility. (H361f)
Precautionary statements
▼General Not applicable.
Prevention
Obtain special instructions before use. (P201) Wear protective gloves/protective clothing/eye protection/face protection. (P280) Do not breathe vapour/mist. (P260)
Response
IF exposed or concerned: Get medical advice/attention. (P308+P313)
Storage
Not applicable.
Disposal
Dispose of contents/container in accordance with local regulation. (P501)
Hazardous Ingredients
Melamine
Additional information
EUH208, Contains 1,2-benzisothiazol-3(2H)- one. May produce an allergic reaction. EUH210, Safety data sheet available on request.
2.3 Other hazards
Additional warnings This mixture/product does not contain any substances known to fulfil the criteria for PBT and vPvB classification. This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2023/707.
